Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

AGEN — Agenus Inc. Dilution Risk Tracker

Track AGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGEN — Get alerts when the score changes →

As of August 28, 2026, Agenus Inc. (AGEN) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Agenus Inc. has a market capitalization of $145.75M, 45.02M shares outstanding, 90 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise model 55%
• Critical: only 2.5 months cash remaining
🔄 Reverse Split model est. 15%
• Only 2 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track AGEN — Get forecast alerts →

Market Data

Market Cap$145.75M
Shares Outstanding45.02M
Float38.63M
Cash$33.38M
Debt$30.07M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.7% shares (2026Q1 vs prior)
90 institutional holders · 12.05M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.88M shares
#2 VANGUARD PORTFOLIO MANAGEMENT LLC 1.20M shares
#3 MORGAN STANLEY 1.13M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.23M
Days to Cover3.0
% of Float16.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-04-06
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-24
4 INSIDER TRANSACTION 2026-03-09
Full SEC filing analysis available with free account

Recent News

No recent news

Factual AGEN Dilution Snapshot

Agenus Inc. (AGEN) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track AGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AGEN
AGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.